GenomeUp vs KAKEHASHI: Revenue, Funding & Team Size Compared
GenomeUp generates $229.9K in revenue; KAKEHASHI generates $222.9K. GenomeUp and KAKEHASHI are close to the same size by revenue. The table below compares GenomeUp and KAKEHASHI on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $229.9K | $222.9K |
| Funding raised | $280.5K | Not disclosed |
| Team size | 31 | 4 |
| Founded | 2017 | 2016 |
| HQ | Rome, Italy | Tokyo, Japan |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
GenomeUp at a glance
GenomeUp generates $229.9K in revenue with 31 employees, headquartered in Rome, Italy.
- Revenue
- $229.9K
- Funding
- $280.5K
- Team size
- 31
- Founded
- 2017
GenomeUp is an AI platform for enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24 hours.
KAKEHASHI at a glance
KAKEHASHI generates $222.9K in revenue with 4 employees, headquartered in Tokyo, Japan.
- Revenue
- $222.9K
- Team size
- 4
- Founded
- 2016
Provider of an electronic medicine history system designed to be used for connecting medical treatment and patients. The company's SaaS based system stores all information related to the health insurance claim and drug history management…
Other GenomeUp alternatives
GenomeUp competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
GenomeUp vs KAKEHASHI: frequently asked questions
Is GenomeUp or KAKEHASHI bigger?
GenomeUp is the bigger company by revenue, at $229.9K against $222.9K for KAKEHASHI.
How much revenue does GenomeUp make?
GenomeUp generates $229.9K in annual revenue with a team of 31.
How much revenue does KAKEHASHI make?
KAKEHASHI generates $222.9K in annual revenue with a team of 4.
How much funding has GenomeUp raised?
GenomeUp has raised $280.5K in total funding since it was founded in 2017.